Hyperpigmentation Disorders Treatment Market Synopsis:
Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market.
The global hyperpigmentation disorders treatment was anticipated to hold a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period.
However, factors such as the lack of adequate reimbursement policy and high costs procedures is estimated to restraint the market.
Get Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7462
Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. According to the American Society of Plastic Surgeons, the number of dermabrasion cosmetic procedures have increased from 42,218 in 2000 to 88,182 in 2016 with a 109% increase during the estimated period.
Some of the key players in the global hyperpigmentation disorders treatment market are
- Allergan Inc.
- Bayer AG
- EpiPharm AG
- Episciences Inc.
- Galderma laboratories (Nestle Skin Health S.A)
- Obagi Cosmeceuticals LLC
- Pierre Fabre
- RXi Pharmaceuticals Corporation
- SkinCeuticals International
- and Vivier Pharma.
The Increasing Demands for Outpatient and Minimally Invasive
Dermabrasion Procedures Include Augmented Adoption of Lasers in Pigmentation Disorders Treatment and Growing Expenditure on The Cosmetics Across the World are Expected to Drive the Growth of the Market.
Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. According to the American Society of Plastic Surgeons, the number of dermabrasion cosmetic procedures have increased from 42,218 in 2000 to 88,182 in 2016 with a 109% increase during the estimated period.
The lack of adequate reimbursement policy and high costs involved in the establishment of these centers may hamper the growth of the market during the assessment period.
Brows Complete Premium Research Report at https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462
Hyperpigmentation Disorders Treatment Market Segmentation:
By Treatment Type
- Topical Drugs
- Chemical Peels
- Laser Therapy
By Disease Indication
- Solar Lentigines
- Post-inflammatory Hyperpigmentation
- Aesthetic Clinics & Dermatology Centers
Hyperpigmentation Disorders Treatment Market Regional Outlook:
The Asia-Pacific are likely to dominate the global hyperpigmentation disorders treatment market. Rising awareness of hyperpigmentation disorders, presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure are some of the factors driving the market.
The Americas stood second in the global hyperpigmentation disorders treatment market owing to government funding and support for healthcare sector.
Moreover, presence of developed economies like US and Canada provides suitable backgrounds for the market growth. Europe is expected to be the third largest hyperpigmentation disorders treatment market.
Following the Europe, the Middle East & Africa is expected to account for the least share of the global hyperpigmentation disorders treatment market.
Ask for Discount at https://www.marketresearchfuture.com/check-discount/7462
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312